iShares U.S. Pharmaceuticals ETF Rating $67.71 -2.85 (-4.04%) As of 02:41 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock iShares U.S. Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IHE Aggregate RatingModerate Buy 2.67Holdings in IHE have an aggregate rating of Moderate Buy based on 365 analyst ratings issued in the past year covering 41 companies (99.9% of the portfolio).IHE Aggregate Price Target$67.780.11% UpsideHigh Prediction$67.78Average Prediction$67.78Low Prediction$67.78Holdings in IHE have an aggregate price target of $67.78 and a range of $67.78 to $67.78 covering 41 companies (99.9% of the portfolio).IHE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy18 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold11 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares U.S. Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 41 IHE Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings24.99%JNJJohnson & Johnson$154.70-6.7%4.8046 of 5 stars2.56$171.33 10.8%18Positive NewsGap Down23.79%LLYEli Lilly and Company$798.41-3.3%4.7981 of 5 stars2.85$1,009.72 26.5%20Positive News4.80%BMYBristol-Myers Squibb$59.33-2.7%3.883 of 5 stars2.33$57.86 -2.5%18Short Interest ↑Positive News4.67%PFEPfizer$24.58-3.0%4.981 of 5 stars2.63$31.92 29.9%164.58%ITCIIntra-Cellular Therapies$131.96+0.0%3.5634 of 5 stars2.47$106.08 -19.6%15News CoveragePositive News4.52%RPRXRoyalty Pharma$31.24+0.4%4.8709 of 5 stars3.00$41.60 33.1%6Positive News4.27%MRKMerck & Co., Inc.$87.05-3.0%5 of 5 stars2.65$117.12 34.5%234.14%ZTSZoetis$162.25-1.5%4.6048 of 5 stars3.08$215.90 33.1%12Positive News3.33%VTRSViatris$8.58-1.5%1.8784 of 5 stars1.75$10.50 22.4%4Short Interest ↑3.00%JAZZJazz Pharmaceuticals$125.63+1.2%4.9083 of 5 stars2.93$187.71 49.4%14Positive News1.89%CORTCorcept Therapeutics$92.60-18.9%4.333 of 5 stars3.00$130.00 40.4%5Analyst ForecastOptions VolumeNews CoverageHigh Trading Volume1.85%ELANElanco Animal Health$10.32-1.7%4.0843 of 5 stars2.43$15.17 46.9%71.81%AXSMAxsome Therapeutics$110.13-5.6%4.7495 of 5 stars3.00$167.64 52.2%15Analyst ForecastShort Interest ↓News CoverageGap Down1.47%PBHPrestige Consumer Healthcare$87.26+1.5%3.7108 of 5 stars2.50$93.33 7.0%6Positive News1.42%OGNOrganon & Co.$14.24-4.4%4.7967 of 5 stars2.43$20.80 46.1%7News CoveragePositive News1.37%PRGOPerrigo$27.62-1.5%4.7997 of 5 stars2.25$33.00 19.5%4Short Interest ↓News Coverage0.73%LGNDLigand Pharmaceuticals$104.20-0.9%4.4759 of 5 stars3.00$147.00 41.1%6Short Interest ↑Positive News0.63%SUPNSupernus Pharmaceuticals$31.57-3.6%2.7645 of 5 stars2.33$36.00 14.0%3Short Interest ↓0.61%TARSTarsus Pharmaceuticals$49.52-3.6%2.7039 of 5 stars3.00$63.67 28.6%70.49%EWTXEdgewise Therapeutics$20.48-6.9%1.9371 of 5 stars2.88$45.38 121.6%80.47%AMRXAmneal Pharmaceuticals$8.25-1.6%3.2656 of 5 stars3.00$10.80 31.0%5News CoveragePositive News0.47%HRMYHarmony Biosciences$32.62-1.7%4.4708 of 5 stars3.00$53.33 63.5%9Positive News0.40%WVEWave Life Sciences$7.80-3.5%4.5535 of 5 stars3.00$22.60 189.7%10Analyst RevisionGap Down0.39%PCRXPacira BioSciences$24.37-1.9%3.6509 of 5 stars2.33$27.22 11.7%9Positive News0.38%ANIPANI Pharmaceuticals$67.69+1.1%3.7798 of 5 stars3.00$79.75 17.8%90.37%AMPHAmphastar Pharmaceuticals$28.27-2.5%4.3249 of 5 stars2.00$43.50 53.9%30.34%COLLCollegium Pharmaceutical$29.12-2.4%4.0453 of 5 stars2.80$43.60 49.7%50.33%OCULOcular Therapeutix$6.67-9.0%3.43 of 5 stars2.88$16.38 145.5%80.33%INVAInnoviva$17.83-1.7%4.444 of 5 stars3.00$55.00 208.6%2Positive News0.30%HROWHarrow$24.64-7.4%2.4697 of 5 stars3.00$61.50 149.6%4Earnings ReportAnalyst Forecast0.26%LQDALiquidia$14.56-1.3%2.5628 of 5 stars3.11$26.63 82.8%9Positive News0.23%EOLSEvolus$11.86-1.5%3.7934 of 5 stars3.00$24.67 108.1%40.22%ELVNEnliven Therapeutics$18.56-5.7%2.6486 of 5 stars3.20$38.75 108.8%5News Coverage0.20%ARVNArvinas$6.99-0.5%3.6371 of 5 stars2.67$35.50 408.2%15Short Interest ↓0.19%OMEROmeros$8.03-2.4%3.5967 of 5 stars2.80$22.50 180.4%5Analyst ForecastNews CoverageGap Up0.18%NUVBNuvation Bio$1.75-0.9%1.9646 of 5 stars3.25$8.75 401.4%40.15%MNMDMind Medicine (MindMed)$5.52-5.7%2.2044 of 5 stars3.23$25.11 355.3%130.12%TBPHTheravance Biopharma$8.98+0.6%1.8003 of 5 stars2.40$13.75 53.1%50.10%PHATPhathom Pharmaceuticals$4.85-22.6%3.2905 of 5 stars3.00$22.17 356.9%6News CoverageGap DownHigh Trading Volume0.03%PLRXPliant Therapeutics$1.33-1.9%4.2015 of 5 stars2.00$13.31 904.7%12Short Interest ↑Gap DownHigh Trading Volume0.03%NMRANeumora Therapeutics$0.90-9.6%3.1873 of 5 stars2.44$10.14 1,022.0%9 This page (NYSEARCA:IHE) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
